NPC
PJP icon

National Planning Corporation’s Invesco Pharmaceuticals ETF PJP Stock Holding History

National Planning Corporation’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,347
Closed -$467K – 719
2016
Q3 		$467K Buy
8,347
+456
+6% +$29.9K 0.04% 378
2016
Q2 		$537K Sell
7,891
-4,923
-38% -$310K 0.04% 355
2016
Q1 		$762K Sell
12,814
-15,028
-54% -$919K 0.07% 279
2015
Q4 		$1.66M Sell
27,842
-4,290
-13% -$304K 0.14% 173
2015
Q3 		$2.33M Buy
32,132
+6,686
+26% +$520K 0.21% 103
2015
Q2 		$2.04M Buy
25,446
+4,414
+21% +$344K 0.18% 120
2015
Q1 		$1.58M Buy
21,032
+5,429
+35% +$399K 0.14% 147
2014
Q4 		$1.05M Buy
15,603
+3,624
+30% +$241K 0.07% 234
2014
Q3 		$767K Buy
11,979
+61
+0.5% +$3.77K 0.06% 300
2014
Q2 		$728K Sell
11,918
-533
-4% -$30.9K 0.06% 310
2014
Q1 		$712K Sell
12,451
-642
-5% -$36.5K 0.06% 297
2013
Q4 		$698K Sell
13,093
-876
-6% -$43.8K 0.06% 296
2013
Q3 		$655K Buy
13,969
+547
+4% +$25K 0.06% 287
2013
Q2 		$566K Buy
+13,422
New +$559K 0.07% 256

Other funds holding PJP

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

National Planning Corporation's PJP Position: Q4 2016 in Review

National Planning Corporation sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2016, closing a stake of 8,347 shares — an estimated $467K sold.

National Planning Corporation first reported a position in PJP in Q2 2013 and held it in 14 quarters. The position peaked at $2.33M in Q3 2015. 101 funds tracked by Wall St. Rank hold PJP as of Q4 2016.

  • National Planning Corporation reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2016 after selling out during the quarter.
  • National Planning Corporation sold 8,347 Invesco Pharmaceuticals ETF shares in Q4 2016, an estimated $467K.
  • National Planning Corporation first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 14 quarters.
  • National Planning Corporation's Invesco Pharmaceuticals ETF position peaked at $2.33M in Q3 2015.
  • 101 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2016.

Based on National Planning Corporation's 13F filing for Q4 2016, filed 7 Feb 2017.